A trend of an increasing number of driver alterations of breast cancer-related genes was observed in recurrence samples as compared to primary tumors, including alterations in FGFR1, ESR1, NF1, BRCA1, and PTEN genes. This evidence concerns the gene ESR1 and breast cancer.